Shôichi Ihara

1.9k total citations
20 papers, 148 citations indexed

About

Shôichi Ihara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Shôichi Ihara has authored 20 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Shôichi Ihara's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Shôichi Ihara is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Shôichi Ihara collaborates with scholars based in Japan, France and Ireland. Shôichi Ihara's co-authors include Seigo Minami, Hiroshi Kida, Kiyoshi Komuta, Atsushi Kumanogoh, Isao Tachibana, Yoshiharu Higuchi, Kensuke Kanaoka, Hironao Yasuoka, Tetsuya Tomita and Ichiro Kawase and has published in prestigious journals such as Scientific Reports, Annals of Oncology and OncoImmunology.

In The Last Decade

Shôichi Ihara

19 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shôichi Ihara Japan 8 69 63 43 28 26 20 148
Ryoichi Honda Japan 8 50 0.7× 82 1.3× 38 0.9× 23 0.8× 29 1.1× 26 183
Carolina Alves Costa Silva France 9 51 0.7× 58 0.9× 52 1.2× 18 0.6× 16 0.6× 24 155
Lishu Zhao China 10 87 1.3× 109 1.7× 74 1.7× 23 0.8× 19 0.7× 30 235
Shinsuke Tsumura Japan 7 178 2.6× 45 0.7× 30 0.7× 55 2.0× 12 0.5× 19 238
Maria Grazia Vitale Italy 10 54 0.8× 126 2.0× 41 1.0× 28 1.0× 30 1.2× 26 209
Dayong Zhu China 7 32 0.5× 86 1.4× 30 0.7× 18 0.6× 34 1.3× 9 176
Marie‐Dominique Tabone France 8 47 0.7× 51 0.8× 68 1.6× 30 1.1× 29 1.1× 15 165
Kinnosuke Matsumoto Japan 7 65 0.9× 53 0.8× 10 0.2× 21 0.8× 16 0.6× 20 109
Yang Dongliang China 7 43 0.6× 24 0.4× 72 1.7× 26 0.9× 38 1.5× 11 157
Takayuki Shimamoto Japan 6 129 1.9× 228 3.6× 79 1.8× 22 0.8× 19 0.7× 8 293

Countries citing papers authored by Shôichi Ihara

Since Specialization
Citations

This map shows the geographic impact of Shôichi Ihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shôichi Ihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shôichi Ihara more than expected).

Fields of papers citing papers by Shôichi Ihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shôichi Ihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shôichi Ihara. The network helps show where Shôichi Ihara may publish in the future.

Co-authorship network of co-authors of Shôichi Ihara

This figure shows the co-authorship network connecting the top 25 collaborators of Shôichi Ihara. A scholar is included among the top collaborators of Shôichi Ihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shôichi Ihara. Shôichi Ihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ihara, Shôichi, et al.. (2022). Lenvatinib-refractory thymic mucinous carcinoma with PIK3CA mutation. International Cancer Conference Journal. 12(1). 36–40. 1 indexed citations
2.
Kunimasa, Kei, Kazumi Nishino, Yoshiharu Sato, et al.. (2022). Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC. Scientific Reports. 12(1). 13544–13544. 5 indexed citations
3.
Kanaoka, Kensuke, Shôichi Ihara, Takeshi Nakatani, & Seigo Minami. (2022). Rituximab for the Treatment of Anti-glomerular Basement Membrane Disease with Isolated Diffuse Alveolar Hemorrhage. Internal Medicine. 62(13). 1971–1975. 2 indexed citations
4.
5.
Ihara, Shôichi, et al.. (2021). Osimertinib-Induced Unilateral Diffuse Alveolar Hemorrhage in a Patient With Pulmonary Adenocarcinoma. Journal of Medical Cases. 12(7). 295–299. 2 indexed citations
6.
Yoshihiro, Shodai, Takashi Hongo, Tadashi Kaneko, et al.. (2021). Steroid treatment in patients with acute respiratory distress syndrome: a systematic review and network meta-analysis. Journal of Anesthesia. 36(1). 107–121. 11 indexed citations
7.
Kanaoka, Kensuke, et al.. (2021). Secondary organizing pneumonia after coronavirus disease 2019: Two cases. Respiratory Medicine Case Reports. 32. 101356–101356. 11 indexed citations
8.
Kanaoka, Kensuke, Seigo Minami, Shôichi Ihara, & Kiyoshi Komuta. (2021). High neutrophils and low lymphocytes percentages in bronchoalveolar lavage fluid are prognostic factors of higher in-hospital mortality in diffuse alveolar hemorrhage. BMC Pulmonary Medicine. 21(1). 288–288. 3 indexed citations
9.
Minami, Seigo, et al.. (2021). Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case. Journal of Medical Cases. 12(9). 359–365. 3 indexed citations
10.
Minami, Seigo, et al.. (2020). Osimertinib-induced cardiac failure with QT prolongation and torsade de pointes in a patient with advanced pulmonary adenocarcinoma. International Cancer Conference Journal. 10(1). 68–71. 22 indexed citations
11.
Minami, Seigo, et al.. (2020). Successful Treatment of Allergic Bronchopulmonary Aspergillosis Using a Combination of Inhaled Fluticasone Furoate/Vilanterol and Oral Voriconazole. Journal of Medical Cases. 11(11). 348–351. 1 indexed citations
12.
Minami, Seigo, Shôichi Ihara, & Kiyoshi Komuta. (2020). Sarcopenia and Visceral Adiposity Are Not Independent Prognostic Markers for Extensive Disease of Small-Cell Lung Cancer: A Single-Centered Retrospective Cohort Study. World Journal of Oncology. 11(4). 139–149. 11 indexed citations
13.
Kanazu, Masaki, Masahide Mori, Madoka Kimura, et al.. (2020). Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study. Thoracic Cancer. 12(1). 90–96. 6 indexed citations
14.
Minami, Toshiyuki, Takashi Kijima, Hisashi Arase, et al.. (2013). Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis. Scientific Reports. 3(1). 2669–2669. 24 indexed citations
15.
Kida, Hiroshi, Shôichi Ihara, & Atsushi Kumanogoh. (2012). Involvement of STAT3 in immune evasion during lung tumorigenesis. OncoImmunology. 2(1). e22653–e22653. 21 indexed citations
16.
17.
Kida, Hiroshi, Mitsuhiro Yoshida, Tetsuya Tomita, et al.. (2011). Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab. Modern Rheumatology. 21(6). 660–664. 12 indexed citations
18.
Kida, Hiroshi, Mitsuhiro Yoshida, Tetsuya Tomita, et al.. (2011). Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab. Modern Rheumatology. 21(6). 660–664. 8 indexed citations
19.
Suzuki, Kazushi, et al.. (1996). [A case of abdominal tuberculous lymphadenitis diagnosed by percutaneous needle biopsy under ultrasound control and followed up by ultrasound imaging].. PubMed. 71(5). 351–5. 1 indexed citations
20.
Ihara, Shôichi, et al.. (1979). Cytologic Study of Intranuclear Cytoplasmic Inclusions of the Thyroid Gland. The Journal of the Japanese Society of Clinical Cytology. 18(3). 302–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryoichi Honda Breakdown of academic impact, for papers by Carolina Alves Costa Silva Breakdown of academic impact, for papers by Lishu Zhao Breakdown of academic impact, for papers by Shinsuke Tsumura Breakdown of academic impact, for papers by Maria Grazia Vitale Breakdown of academic impact, for papers by Dayong Zhu Breakdown of academic impact, for papers by Marie‐Dominique Tabone Breakdown of academic impact, for papers by Kinnosuke Matsumoto Breakdown of academic impact, for papers by Yang Dongliang Breakdown of academic impact, for papers by Takayuki Shimamoto
Rankless by CCL
2026